Screener
CG Oncology CGON Current ratio
Current ratio at other companies
Other financials
Where this comes from
Calculated from CG Oncology’s reported figures.
Based on the most recent quarter.
The source filing: CG Oncology’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 8:45 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-336918
FAQ
- What is CG Oncology's current ratio?
- CG Oncology (CGON) reported current ratio of 22.2× in Q2 2026.
- How has CG Oncology's current ratio changed year-over-year?
- CG Oncology's current ratio increased by 0.3% year-over-year, from 22.2× to 22.2×.
- What is the long-term trend for CG Oncology's current ratio?
- Over 2 years (2023 to 2025), CG Oncology's current ratio has grown at a 34.5% compound annual growth rate (CAGR), from 13.6× to 24.6×.
- What does current ratio mean?
- Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.
Ask your AI about CG Oncology's current ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude